http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-108008042-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8b0366de8424f06ea34ef51375898d0a |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N30-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N30-06 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N30-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N30-02 |
| filingDate | 2017-12-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1553fd408160c94073215406deb6c1d3 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_381cda105f4e42c507660741b38dfbc8 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bb670c44c9ef5e2a00c7248943ee71fb http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7a37d34b69f867831d8ca248203ef41c |
| publicationDate | 2018-05-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-108008042-A |
| titleOfInvention | A kind of content assaying method of four kinds of saponin components of Paris polyphylla detoxification tincture preparation |
| abstract | The invention discloses chonglou saponin I in a kind of Paris polyphylla detoxification tincture preparation, chonglou saponin Ⅱ, IV 4 kinds of active ingredient of chonglou saponin III and chonglou saponin content assaying method.It is reference substance with chonglou saponin I, chonglou saponin Ⅱ, chonglou saponin III and chonglou saponin IV, with acetonitrile（A）Water (B)/0~15min30% of gradient elution~40%A；15~40min40%A；The high performance liquid chromatography of 40~70min40%~60%A mobile phases.Compared with prior art, for the present invention to measure four kinds of active constituent contents at the same time, quality general introduction is comprehensive, specificity is strong, and stability is high, and measurement result is accurate, effective control said preparation quality is achieveed the purpose that, it is ensured that the safety of the stabilization and clinical application of said preparation and its Related product quality. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-113960233-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-114441685-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-114441685-B |
| priorityDate | 2017-12-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 45.